Mike Albright's In Vivo Spectroscopy F-19 References

F-19 References:

  1. Mattrey, R. F., "Perfluorocarbon Compounds: Applications in Diagnostic Imaging". Proceedings of The Society of Photo-Optical Instrumentation Engineers, 626:18-23, 1986.
  2. Dungan, C. H.; Van Wazer, J. R., Compilation of Reported F19 NMR Chemical Shifts, 1951 to Mid-1967, Wiley-Interscience, 1970.
  3. Thomas, S. R., "The Application of Fluorine-19 NMR in Medicine". Proceedings of The Society of Photo-Optical Instrumentation Engineers, 626:7-17, 1986.
  4. McFarland, E.; Koutcher, J. A.; Rosen, B. R.; Teicher, B.; Brady, T. J., "In vivo 19F NMR Imaging". J. Comput. Assist. Tomogr., 9:8-15, 1985.
  5. Holland, G. N.; Bottomley, P. A.; Hinshaw, W. S., "19F Magnetic Resonance Imaging". J. Magn. Reson., 28:133-136, 1977.
  6. Busse, L. J.; Thomas, S. R.; Pratt, R. G.; et. al., "Deconvolution Techniques for Removing the Effects of Chemical Shift in 19F Nuclear Magnetic Resonance Imaging of Perfluorocarbon Compounds". Med. Phys. , 13:518-524, 1986.
  7. Wyrwicz, A. M.; Li, Y.; Schofield, J. C.; Burt, C. T., "Mutiple Environments of Fluorinated Anesthetics in Intact Tissues Observed with 19F NMR Spectroscopy". FEBS Letters, 162:334-338, 1983.
  8. Mills, P.; Mosely, M.; Sessler, D.; et. al., "19F MRS Study of Isoflurane Elimination from the Adult Rabbit Brain". Scientific Program of the Society of Magnetic Resonance in Medicine, 251-252, 1986.
  9. Wyrwicz, A. M.; Pszenny, M. H.; Schofield, J. C.; et al., "Noninvasive Observations of Fluorinated Anesthetics in Rabbit Brain by Fluorine-19 Nuclear Magnetic Resonance". Science, 222:428-430, 1983.
  10. Moore, R. R.; Brown, T.; Burt, C. T.; Roberts, M. F., "In Vivo F-19 NMR Studies of Halothane in Rat Tissues". Scientific Program of the Society of Magnetic Resonance in Medicine, 510-511, 1985.
  11. Litt, L.; Gonzalez-Mendez, R.; James, T. L.; et. al., "An In Vivo F-19 NMR Study at 5.6 Tesla of Halothane Uptake and Elimination in Anesthetized Rats". Scientific Program of the Society of Magnetic Resonance in Medicine, 1343-1344, 1986.
  12. Conboy, C. B.; Wyrwicz, A. M., "Localization of Halothane with F-19 NMR Rotating-Frame Zuegmatography". Scientific Program of the Society of Magnetic Resonance in Medicine, 775-776, 1985.
  13. Burt, C. T.; Moore, R. R.; Roberts, M. F., "Fluorinated Anesthetics as Probes of Lipophilic Environments in Tumors". J. Magn. Reson., 53:163-166, 1983.
  14. Higuchi, T.; Naruse, S.; Horikawa, Y.; et. al., "In Vivo 19F-NMR Spectroscopic Study of Normal and Pathological Brains". Scientific Program of the Society of Magnetic Resonance in Medicine, 795-796, 1985.
  15. Nunnally, R. L.; Babcock, E. E.; Horner, S. D.; Peshock, R. M., "Fluorine-19 NMR Spectroscopy and Imaging Investigations of Myocardial Perfusion and Cardiac Function". Magn. Reson. Imaging, 3:399-405, 1985.
  16. Bolas, N. M.; Petros, A. J.; Bergel, D.; Radda, G. K., "Use of 19F Magnetic Resonance Spectroscopy for Measurement of CerebralBlood Flow". Scientific Program of the Society of Magnetic Resonance in Medicine, 315-316, 1985.
  17. Joseph, P. M.; Fishman, J. E.; Mukherji, B.; Sloviter, H. A., "Vascular Imaging in Rats with 19F MRI". Scientific Program of the Society of Magnetic Resonance in Medicine, 995-996, 1985.
  18. Fishman, J. E.; Floyd, T.; Sloviter, H. A.; Ziegler, M., "Oxygenation in Perfused Rabbit Kidney by 19F NMR Imaging". Scientific Program of the Society of Magnetic Resonance in Medicine, 858-859, 1985.
  19. Nichols, B. G.; Hein, L.; Anderson, L.; et. al., "19F NMR of Blood Substitute FC-43: In Vivo T1's and O2 Effects". Scientific Program of the Society of Magnetic Resonance in Medicine, 808-809, 1985.
  20. Bartels, M.; Albert, K.; Kruppa, G.; et. al., "Fluorinated Psychopharmacologic Agents: Noninvasive Observation by Fluorine-19 Nuclear Magnetic Resonance". Scientific Program of the Society of Magnetic Resonance in Medicine, 755-756, 1985.
  21. Eleff, S.; Ligetti, L.; Osbakken, M.; et. al., "Brain Blood Flow Using 19F NMR with Simultaneous Phosphorus Metabolite Monitoring". Scientific Program of the Society of Magnetic Resonance in Medicine, 119-120, 1986.
  22. Wyrwicz, A. M.; Murphy, R.; Moriarty, R. M.; Dougherty, T., "2-Fluoro-2-Deoxy-D-Glucose Metabolism in Rat Brain". Scientific Program of the Society of Magnetic Resonance in Medicine, 827-828, 1985.
  23. Kwee, I. L.; Nakada, T.; Card, P. J., "19F 3-FDG NMR In Vivo Spectroscopy in Rat Brain: Another Model of Cerebral Glucose Metabolism". Scientific Program of the Society of Magnetic Resonance in Medicine, 1339-1340, 1986.
  24. Berkowitz, B. A.; Kin, S.; Ackerman, J. J. H., "2-Fluoro-2-Deoxy-D-Glucose Metabolism in Cerebral Tissue In Vivo: A 19F , 31P NMR Investigation". Scientific Program of the Society of Magnetic Resonance in Medicine, 257-258, 1986.
  25. Babcock, E. E.; Nunnally, R. L., "In Vivo and In Vitro Determination of 2-Fluoro-2-Deoxy-D-Glucose by F-19 NMR Imaging and Spectroscopy". Scientific Program of the Society of Magnetic Resonance in Medicine, 751-752, 1985.
  26. Berkowitz, B. A.; Ackerman, J. J. H., "2-Fluoro-2-Deoxy-D-Glucose (2DFG) Metabolism In Vivo: A 19F-{1H} NMR Study". Scientific Program of the Society of Magnetic Resonance in Medicine, 759-780, 1985.
  27. Nakada, T.; Kwee, I. L., "Non-Invasive Demonstration of In Vivo 2-Fluoro-2-Deoxy-D-Glucose Metabolism in Rat Brain by 19F NMR". Scientific Program of the Society of Magnetic Resonance in Medicine, 806-807, 1985.
  28. Nunnally, R. L.; Babcock, E. E.; Antich, P., "The Direct Observation of 5-Fluorouracil Metabolism by the Liver in the Intact Rabbit: A19F NMR Study" Scientific Program of the Society of Magnetic Resonance in Medicine, 810-811, 1985.
  29. Stevens, A. N.; Morris, P. G.; Iles, R. A.; Sheldon, P. W.; Griffiths, J. R., "5-Fluorouracil Metabolism Monitored In Vivo by 19F NMR". Br. J. Cancer, 50:113-117, 1984.
  30. Malet-Martino, M. C.; Martino, R.; Lopez, A.; et al., "New Approach to Metabolism of 5'-Deoxy-5-fluorouridine in Humans with Fluorine-19 NMR". Cancer Chemother. Pharmacol., 13:31-35, 1984.
  31. Bernadou, J.; Armand, J. P.; Malet-Martino, M. C.; Martino, R., "Complete Urinary Excretion Profile of 5-Fluorouracil During a Six-Day Chemotherapeutic Schedule, as Resolved by 19F NuclearMagnetic Resonance". Clin. Chem., 31:846-848, 1985.
  32. Hull, W. E.; Port, R.; Osswald, H.; et. al., "In Vivo 19F NMR Study of 5-Fluorouracil Metabolism in Liver and Implanted Tumors of the Mouse". Scientific Program of the Society of Magnetic Resonance in Medicine, 594-595, 1986.
  33. Prior, M. J. W.; Maxwell, R. J.; Prysor-Jones, R. A.; et. al., "The Role of Magnetic Resonance Spectroscopy in Assessing Drug Delivery to Tumors". Scientific Program of the Society of Magnetic Resonance in Medicine, 740-741, 1985.
  34. Wolf, W.; Silver, M.; Weber, H.; et. al., "A Non-Invasive F-19 NMR Spectroscopic Study of the Metabolism of 5-Fluorouracil inthe Liver of Patients". Scientific Program of the Society of Magnetic Resonance in Medicine, 653-654, 1986.
  35. Wolf, W., Albright, M.J., Silver, M.S., Weber, H., Reichardt, U., and Sauer, R., "Fluorine-19 NMR Spectroscopic Studies of the Metabolism of 5-Fluorouracil in the Liver of Patients Undergoing Chemotherapy". Magnetic Resonance Imaging, 5:165-169, 1987.
  36. Wolf, W., Presant, C.A., Servis, K.L., El-Tahtawy, A., Albright, M.J., Barker, P.B., Ring, R., Atkinson, D., Ong, R., King, M., Singh, M., Ray, M., Wiseman, C., Blayney, D., and Shani, J., "Tumor Trapping of 5-Fluorouracil: In Vivo 19F NMR Spectroscopic Pharmacokinetics in Tumor-bearing Humans and Rabbits". Proc. Natl. Acad. Sci. USA, 87:492-496, 1990.
  37. Presant, C.A., Wolf, W., Albright, M.J., Servis, K.L., Ring, R., Atkinson, D., Ong, R., Wiseman, C., King, M., Blayney, D., Kennedy, P., El-Tahtawy, A., Singh, M., and Shani, J., "Human Tumor Fluorouracil Trapping: Clinical Correlations of In Vivo 19F Nuclear Magnetic Resonance Spectroscopy Pharmacokinetics". J. Clini. Oncol., 8:1868-1873, 1990.
  38. Longmaid, H. E. III; Adams, D. F.; Neirinckx, R. D.; et al., "In vivo 19F Imaging of Liver, Tumor, and Abscess in Rats: Preliminary Results". Invest. Radiol., 20:141-145, 1985.
  39. Burt, C. T. ;Eisemann, A.; Schofield, J. C.; Wyrwicz, A. M., "Nuclear Magnetic Resonance Studies on Circulating Blood". J. Magn. Reson., 46:176-179, 1982.
  40. Gochin, M.; James, T. L.; Shafer, R. H., "In Vivo 19F-NMR of 5-fluorouracil Incorporation into RNA and Metabolites in Escherichia Coli Cells". Biochim. Biophys. Acta., 804:118-124, 1984.
  41. Malet-Martino, M. C.; Martino, R.; Lopez, A.; et al., "Detection of Fluoropyrimidines and Their Metabolites in Biological Samples by Fluorine-19 NMR: Application to 5'-Deoxy-5-fluorouridine". Biomedicine and Pharmacotherapy, 37:357-359, 1983.
  42. Burt, C. T.; Moore, R. R; Roberts, M. F.; Brady, T. J., "The Fluorinated Anesthetic Halothane as a Potential NMR Biologic Probe". Biochim. Biophys. Acta, 805:375-381, 1984.
  43. Moore, R. R; Roberts, M. F., "Correlation of 19F-NMR Spectra of Halothane in Rat Tumor and Non-tumor tissues with Membrane Alterations". Biochim. Biophys. Acta, 844:346-351, 1985.
  44. Nakada, T.; Kwee, I. L.; Conboy, C. B., "Noninvasive In Vivo Demonstration of 2-Fluoro-2-Deoxy-D-Glucose Metabolism Beyond the Hexokinase Reaction in Rat Brain by 19F Nuclear Magnetic Resonance Spectroscopy". J. Nuerochem., 46:198-201, 1986.
  45. Malet-Martino, M. C.; Betbeder, D; Lattes, A.; et al., "Fluosol 43 Intravascular Persistence in Mice Measured by 19F NMR". J. Pharm. Pharmacol., 36:556-559, 1984.
  46. Martino, R.; Lopez, A.; Malet-Martino, M. C.; et al., "Release of Fluoride Ion from 5'-Deoxy-5-fluorouridine, an Antieoplastic Fluoropyrimidine, in Humans". Drug Metab. Dispos., 13:116-118, 1985.
  47. Nelson, T. R.; Newman, F. D.; Schiffer, L. M.; et. al., "Fluorine Nuclear Magnetic Resonance: Calibration and System Optimization". Magn. Reson. Imaging, 3:267-273, 1985.